 CVS Health Corp. is moving closer to a deal to buy Aetna Inc. for more than $66 billion in cash and stock. The deal, which could be announced by Monday, would create a health-care-industry behemoth selling everything from drugs to insurance.The companies are in advanced stages of negotiating a deal, according to people familiar with the matter. It would likely be valued at between $200 and $205 per Aetna share and be comprised mainly of cash, some of the people said. The cash-stock mix has yet to be finalized and Aetna has...
  
Subscribe NowSign In
WSJ MembershipCustomer ServiceTools & FeaturesAdsMore